Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Assembly Biosciences, Inc. is a biotechnology company focused on developing innovative therapeutics for serious viral diseases. Its pipeline includes clinical-stage therapies targeting recurrent genital herpes, hepatitis delta virus (HDV), and hepatitis B virus (HBV). With significant market opportunities, Assembly aims to address unmet medical needs through collaborations, notably with Gilead Sciences. The company is advancing multiple candidates towards clinical readouts, enhancing treatment options for patients worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.